Goldman Sachs’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-338,888
Closed -$1.29M 4663
2020
Q1
$1.29M Buy
338,888
+38,120
+13% +$145K ﹤0.01% 2984
2019
Q4
$1.53M Buy
300,768
+121,182
+67% +$617K ﹤0.01% 3093
2019
Q3
$908K Buy
179,586
+68,231
+61% +$345K ﹤0.01% 3301
2019
Q2
$687K Sell
111,355
-224,374
-67% -$1.38M ﹤0.01% 3388
2019
Q1
$1.56M Buy
335,729
+39,968
+14% +$185K ﹤0.01% 3057
2018
Q4
$1.24M Sell
295,761
-21,980
-7% -$92.4K ﹤0.01% 3037
2018
Q3
$1.99M Sell
317,741
-21,269
-6% -$133K ﹤0.01% 2885
2018
Q2
$2.73M Buy
339,010
+115,003
+51% +$925K ﹤0.01% 2733
2018
Q1
$1.67M Sell
224,007
-23,963
-10% -$179K ﹤0.01% 2961
2017
Q4
$1.48M Buy
247,970
+32,242
+15% +$192K ﹤0.01% 2978
2017
Q3
$1.59M Sell
215,728
-97,278
-31% -$716K ﹤0.01% 2984
2017
Q2
$2.13M Sell
313,006
-521,736
-63% -$3.54M ﹤0.01% 2766
2017
Q1
$7.88M Buy
834,742
+563,534
+208% +$5.32M ﹤0.01% 1958
2016
Q4
$2.34M Sell
271,208
-669,130
-71% -$5.78M ﹤0.01% 2618
2016
Q3
$5.95M Buy
940,338
+889,454
+1,748% +$5.63M ﹤0.01% 2144
2016
Q2
$215K Buy
50,884
+30,299
+147% +$128K ﹤0.01% 3823
2016
Q1
$90K Sell
20,585
-124,865
-86% -$546K ﹤0.01% 4057
2015
Q4
$891K Sell
145,450
-37,460
-20% -$229K ﹤0.01% 2956
2015
Q3
$1.05M Buy
182,910
+20,457
+13% +$117K ﹤0.01% 2891
2015
Q2
$1.21M Buy
162,453
+78,216
+93% +$584K ﹤0.01% 2854
2015
Q1
$504K Buy
84,237
+25,617
+44% +$153K ﹤0.01% 3311
2014
Q4
$443K Buy
58,620
+9,696
+20% +$73.3K ﹤0.01% 3448
2014
Q3
$254K Sell
48,924
-10,334
-17% -$53.7K ﹤0.01% 3782
2014
Q2
$255K Sell
59,258
-8,352
-12% -$35.9K ﹤0.01% 3821
2014
Q1
$277K Sell
67,610
-46,110
-41% -$189K ﹤0.01% 3730
2013
Q4
$606K Buy
113,720
+27,636
+32% +$147K ﹤0.01% 3318
2013
Q3
$432K Sell
86,084
-7,268
-8% -$36.5K ﹤0.01% 3395
2013
Q2
$416K Buy
+93,352
New +$416K ﹤0.01% 3271